- Home
- VINP vs ARCT Comparison
VINP vs ARCT Comparison
Compare VINP & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VINP
- ARCT
- Stock Information
- Founded
- VINP 2009
- ARCT 2013
- Country
- VINP Brazil
- ARCT United States
- Employees
- VINP N/A
- ARCT N/A
- Industry
- VINP Investment Managers
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- VINP Finance
- ARCT Health Care
- Exchange
- VINP Nasdaq
- ARCT Nasdaq
- Market Cap
- VINP 593.2M
- ARCT 298.3M
- IPO Year
- VINP 2021
- ARCT N/A
- Fundamental
- Price
- VINP $9.48
- ARCT $14.48
- Analyst Decision
- VINP Strong Buy
- ARCT Strong Buy
- Analyst Count
- VINP 2
- ARCT 8
- Target Price
- VINP $13.25
- ARCT $52.83
- AVG Volume (30 Days)
- VINP 55.0K
- ARCT 467.0K
- Earning Date
- VINP 08-06-2025
- ARCT 08-04-2025
- Dividend Yield
- VINP 6.76%
- ARCT N/A
- EPS Growth
- VINP N/A
- ARCT N/A
- EPS
- VINP 0.38
- ARCT N/A
- Revenue
- VINP $126,696,258.00
- ARCT $143,680,000.00
- Revenue This Year
- VINP $70.28
- ARCT N/A
- Revenue Next Year
- VINP $14.37
- ARCT $34.79
- P/E Ratio
- VINP $25.27
- ARCT N/A
- Revenue Growth
- VINP 57.51
- ARCT 15.38
- 52 Week Low
- VINP $8.66
- ARCT $8.04
- 52 Week High
- VINP $11.62
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- VINP 44.44
- ARCT 63.28
- Support Level
- VINP $9.43
- ARCT $13.10
- Resistance Level
- VINP $9.94
- ARCT $14.09
- Average True Range (ATR)
- VINP 0.20
- ARCT 0.96
- MACD
- VINP -0.00
- ARCT 0.09
- Stochastic Oscillator
- VINP 13.33
- ARCT 97.14
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.